Stay updated on Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdds Publications references from PubMed and a Publications section to the study record. It also lists the Principal Investigator (Jin Li), Shanghai East Hospital as a location, and sponsor and collaborators, enriching the institutional context of the study.SummaryDifference56%

- Check15 days agoChange DetectedThe page now shows revision v3.6.5, replacing v3.6.4, indicating a refreshed version of the page. This appears to be a minor maintenance update rather than a change to the study data or user-facing content.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page revision number was updated from v3.6.3 to v3.6.4, indicating a minor update to the document.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, indicating a minor update to the page metadata or backend; the visible study details and layout remain unchanged.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2. This indicates a platform update and does not alter the study information presented on the page.SummaryDifference0.1%

- Check73 days agoChange DetectedEnrollment status was updated to indicate no further participant recruitment. The page additionally adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and adjusts the Intervention/Treatment heading, including a Revision note (Revision: v3.6.0).SummaryDifference0.4%

Stay in the know with updates to Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page.